active in marijuana compound called tetrahydrocannabinol (THC) has been found to promote the elimination of toxic groups beta amyloid protein in the brain, which is believed to boost the progression of Alzheimer’s disease.
The finding supports the results of previous studies that found evidence of the protective effects of THC cannabinoids, including in patients with neurodegenerative disease.
“Although other studies have provided evidence that cannabinoids may be neuroprotective against the symptoms of Alzheimer’s disease, we believe our study is the first to demonstrate that cannabinoids affect both inflammation and accumulation beta amyloid in nerve cells, “says one team, David Schubert of the Salk Institute for biological Studies in California.
Schubert and his colleagues tested the effects of THC on human neurons grown in the laboratory that mimic the effects of Alzheimer’s disease.
If you are not familiar with this special little compound, which is not only responsible for most of the psychological effects of marijuana – including high – thanks to its natural properties to relieve pain, but also it has been touted as an effective treatment for the symptoms of everything from HIV and chemotherapy for chronic pain, PTSD, and stroke.
Indeed, THC seems to be a medical agent so surprising, researchers are working on breeding genetically modified yeast that can produce more efficiently than it would be to make synthetic versions manner.